Fairman Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15
Closed -$91 337
2026
Q1
$91 Hold
15
﹤0.01% 318
2025
Q4
$108 Hold
15
﹤0.01% 324
2025
Q3
$162 Hold
15
﹤0.01% 265
2025
Q2
$146 Hold
15
﹤0.01% 250
2025
Q1
$226 Sell
15
-50
-77% -$769 ﹤0.01% 243
2024
Q4
$972 Hold
65
﹤0.01% 276
2024
Q3
$1.25K Hold
65
﹤0.01% 319
2024
Q2
$1.35K Hold
65
﹤0.01% 309
2024
Q1
$1.22K Hold
65
﹤0.01% 315
2023
Q4
$939 Buy
+65
New +$884 ﹤0.01% 327

Other funds holding OGN

Fairman Group's OGN Position: Q2 2026 in Review

Fairman Group sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 15 shares — an estimated $91 sold.

Fairman Group first reported a position in OGN in Q4 2023 and held it in 10 quarters. The position peaked at $1.35K in Q2 2024. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Fairman Group reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Fairman Group sold 15 Organon & Co shares in Q2 2026, an estimated $91.
  • Fairman Group first reported a position in Organon & Co in Q4 2023 and held it in 10 quarters.
  • Fairman Group's Organon & Co position peaked at $1.35K in Q2 2024.
  • 635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.